Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Biliary Tract Cancer
- Clear Cell Renal Cell Carcinoma
- Gastric Adenocarcinoma
- Gastro-oesophageal Adenocarcinoma
- Head and Neck Cancer
- Platinum-sensitive Urothelial Bladder Cancer
- Urothelial Bladder Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04779151
- Collaborators
- Not Provided
- Investigators
- Not Provided